Internet-based Treatment of Generalized Anxiety Disorder
This study is currently recruiting participants.
Verified March 2012 by Umeå University
Sponsor:
Information provided by (Responsible Party):
Per Carlbring, PhD, Umeå University
ClinicalTrials.gov Identifier:
NCT01570374
First received: March 31, 2012
Last updated: April 3, 2012
Last verified: March 2012
| March 31, 2012 |
| April 3, 2012 |
| January 2012 |
| January 2013 (final data collection date for primary outcome measure) |
- Change from baseline in Penn State Worry Questionnaire (PSWQ) [ Time Frame: 24 hours ] [ Designated as safety issue: No ]
Measures anxiety symtoms related to Generalized Anxiety Disorder. 16 items.
- Change from baseline in Penn State Worry Questionnaire (PSWQ) [ Time Frame: 6 months ] [ Designated as safety issue: No ]
Measures anxiety symtoms related to Generalized Anxiety Disorder. 16 items.
- Change from baseline in Penn State Worry Questionnaire (PSWQ) [ Time Frame: 12 months ] [ Designated as safety issue: No ]
Measures anxiety symtoms related to Generalized Anxiety Disorder. 16 items.
- Change from baseline in Penn State Worry Questionnaire (PSWQ) [ Time Frame: 24 months ] [ Designated as safety issue: No ]
Measures anxiety symtoms related to Generalized Anxiety Disorder. 16 items.
|
| Same as current |
| Complete list of historical versions of study NCT01570374 on ClinicalTrials.gov Archive Site |
- Change from baseline in Beck Anxiety Inventory (BAI) [ Time Frame: 24 hours ] [ Designated as safety issue: No ]
21 item rating scale for anxiety symptoms.
- Change from baseline in Beck Anxiety Inventory (BAI) [ Time Frame: 6 months ] [ Designated as safety issue: No ]
21 item rating scale for anxiety symptoms.
- Change from baseline in Beck Anxiety Inventory (BAI) [ Time Frame: 12 months ] [ Designated as safety issue: No ]
21 item rating scale for anxiety symptoms.
- Change from baseline in Beck Anxiety Inventory (BAI) [ Time Frame: 24 months ] [ Designated as safety issue: No ]
21 item rating scale for anxiety symptoms.
- Change from baseline in Quality Of Life Inventory (QOLI) [ Time Frame: 24 hours ] [ Designated as safety issue: No ]
The QOLI assessment yields an overall score and a profile of problems and strengths in 16 areas of life such as love, work and play. The QOLI test is a measure of positive psychology and positive mental health.
- Change from baseline in Quality Of Life Inventory (QOLI) [ Time Frame: 6 months ] [ Designated as safety issue: No ]
The QOLI assessment yields an overall score and a profile of problems and strengths in 16 areas of life such as love, work and play. The QOLI test is a measure of positive psychology and positive mental health.
- Change from baseline in Quality Of Life Inventory (QOLI) [ Time Frame: 12 months ] [ Designated as safety issue: No ]
The QOLI assessment yields an overall score and a profile of problems and strengths in 16 areas of life such as love, work and play. The QOLI test is a measure of positive psychology and positive mental health.
- Change from baseline in Quality Of Life Inventory (QOLI) [ Time Frame: 24 months ] [ Designated as safety issue: No ]
The QOLI assessment yields an overall score and a profile of problems and strengths in 16 areas of life such as love, work and play. The QOLI test is a measure of positive psychology and positive mental health.
- Change from baseline in Montgomery-Åsberg Depression Rating Scale (MADRS) [ Time Frame: 24 hours ] [ Designated as safety issue: No ]
9-item depression rating scale.
- Change from baseline in Montgomery-Åsberg Depression Rating Scale (MADRS) [ Time Frame: 6 months ] [ Designated as safety issue: No ]
9-item depression rating scale.
- Change from baseline in Montgomery-Åsberg Depression Rating Scale (MADRS) [ Time Frame: 12 months ] [ Designated as safety issue: No ]
9-item depression rating scale.
- Change from baseline in Montgomery-Åsberg Depression Rating Scale (MADRS) [ Time Frame: 24 months ] [ Designated as safety issue: No ]
9-item depression rating scale.
- Change from baseline in Patient Health Questionnaire (PHQ-9) [ Time Frame: Weekly during treatment period ] [ Designated as safety issue: No ]
The PHQ-9 is the nine item depression scale of the Patient Health Questionnaire. The PHQ-9 is a powerful tool for assisting primary care clinicians in diagnosing depression as well as selecting and monitoring treatment. The PHQ-9 is based directly on the diagnostic criteria for major depressive disorder in the Diagnostic and Statistical Manual Fourth Edition (DSM-IV).
- Change from baseline in Patient Health Questionnaire (PHQ-9) [ Time Frame: 24 hours ] [ Designated as safety issue: No ]
The PHQ-9 is the nine item depression scale of the Patient Health Questionnaire. The PHQ-9 is a powerful tool for assisting primary care clinicians in diagnosing depression as well as selecting and monitoring treatment. The PHQ-9 is based directly on the diagnostic criteria for major depressive disorder in the Diagnostic and Statistical Manual Fourth Edition (DSM-IV).
- Change from baseline in Patient Health Questionnaire (PHQ-9) [ Time Frame: 6 months ] [ Designated as safety issue: No ]
The PHQ-9 is the nine item depression scale of the Patient Health Questionnaire. The PHQ-9 is a powerful tool for assisting primary care clinicians in diagnosing depression as well as selecting and monitoring treatment. The PHQ-9 is based directly on the diagnostic criteria for major depressive disorder in the Diagnostic and Statistical Manual Fourth Edition (DSM-IV).
- Change from baseline in Patient Health Questionnaire (PHQ-9) [ Time Frame: 12 months ] [ Designated as safety issue: No ]
The PHQ-9 is the nine item depression scale of the Patient Health Questionnaire. The PHQ-9 is a powerful tool for assisting primary care clinicians in diagnosing depression as well as selecting and monitoring treatment. The PHQ-9 is based directly on the diagnostic criteria for major depressive disorder in the Diagnostic and Statistical Manual Fourth Edition (DSM-IV).
- Change from baseline in Patient Health Questionnaire (PHQ-9) [ Time Frame: 24 months ] [ Designated as safety issue: No ]
The PHQ-9 is the nine item depression scale of the Patient Health Questionnaire. The PHQ-9 is a powerful tool for assisting primary care clinicians in diagnosing depression as well as selecting and monitoring treatment. The PHQ-9 is based directly on the diagnostic criteria for major depressive disorder in the Diagnostic and Statistical Manual Fourth Edition (DSM-IV).
- Change from baseline in Generalized Anxiety Disorder-7 (GAD-7) [ Time Frame: Weekly during treatment period ] [ Designated as safety issue: No ]
7-item screening form for Generalized Anxiety Disorder.
- Change from baseline in Generalized Anxiety Disorder-7 (GAD-7) [ Time Frame: 24 hours ] [ Designated as safety issue: No ]
7-item screening form for Generalized Anxiety Disorder.
- Change from baseline in Generalized Anxiety Disorder-7 (GAD-7) [ Time Frame: 6 months ] [ Designated as safety issue: No ]
7-item screening form for Generalized Anxiety Disorder.
- Change from baseline in Generalized Anxiety Disorder-7 (GAD-7) [ Time Frame: 12 months ] [ Designated as safety issue: No ]
7-item screening form for Generalized Anxiety Disorder.
- Change from baseline in Generalized Anxiety Disorder-7 (GAD-7) [ Time Frame: 24 months ] [ Designated as safety issue: No ]
7-item screening form for Generalized Anxiety Disorder.
|
| Same as current |
| Not Provided |
| Not Provided |
| |
| Internet-based Treatment of Generalized Anxiety Disorder |
| Internet-based Treatment of Generalized Anxiety Disorder |
The purpose of this study is to determine whether internet-administered cognitive behavior therapy is a feasible treatment for generalized anxiety disorder. |
| Not Provided |
| Interventional |
| Not Provided |
Allocation: Randomized Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Generalized Anxiety Disorder |
| Behavioral: Internet-based cognitive behavioral therapy (iCBT)
9 week internet-administered, therapist-assisted, controlled-progression cognitive behavioral therapy (iCBT). Individualized and disorder-specific. |
- Experimental: iCBT
Receives treatment.
Intervention: Behavioral: Internet-based cognitive behavioral therapy (iCBT)
- No Intervention: Waiting list control group
The waiting list control group initially receives no treatment, but do weekly screenings. After 9 weeks, the control group receives the same treatment as the other study arm.
Intervention: Behavioral: Internet-based cognitive behavioral therapy (iCBT)
|
| Not Provided |
| |
| Recruiting |
| 128 |
| January 2014 |
| January 2013 (final data collection date for primary outcome measure) |
Inclusion Criteria:
- Satisfy DSM-IV criteria for generalized anxiety disorder
- Living in Sweden and being able to read Swedish
- Access to computer with internet connection
Exclusion Criteria:
- Currently receiving other psychological treatment
- Non-stable use of psychoactive medication
- Deemed suicidal
- Deemed to suffer from other psychological disorder, e.g. psychosis, bipolarity etc.
|
| Both |
| 18 Years and older |
| No |
|
|
| Sweden |
| |
| NCT01570374 |
| Oroshjalpen |
| No |
| Per Carlbring, PhD, Umeå University |
| Umeå University |
| Not Provided
| Principal Investigator: |
Per Carlbring, Professor |
Department of Psychology, Umeå University |
|
|
| Umeå University |
| March 2012 |